MSI
49
5
PVH
28
-2
O
31
-2
ORLY
43
2
RF
64
-3
ZBH
42
-2
SPG
50
2
PFE
41
-4
VTR
67
-2
PEP
29
-3
LYB
20
-3
CINF
61
-5
ADT
46
-4
BEN
55
-2
OMC
64
-2
EIX
56
-3
VLO
42
2
PEG
46
-4
JPM
73
2
NKE
33
2
MSI
49
5
PVH
28
-2
O
31
-2
ORLY
43
2
RF
64
-3
ZBH
42
-2
SPG
50
2
PFE
41
-4
VTR
67
-2
PEP
29
-3
LYB
20
-3
CINF
61
-5
ADT
46
-4
BEN
55
-2
OMC
64
-2
EIX
56
-3
VLO
42
2
PEG
46
-4
JPM
73
2
NKE
33
2
Financhill
Back

LMP Capital and Income Fund Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
79

SCD
LMP Capital and Income Fund

Last Price:
$14.80
Seasonality Move:
1.17%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$71.39
Seasonality Move:
-34.19%
Buy
79
LMP Capital and Income Fund (SCD) is a Buy

Is LMP Capital and Income Fund a Buy, Sell or Hold?

  • The current LMP Capital and Income Fund [SCD] share price is $14.84. The Score for SCD is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • SCD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SCD Stock Price Chart

What is LMP Capital and Income Fund's stock price today?

  • The LMP Capital and Income Fund share price today is $14.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCD is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SCD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.27 Buy
Relative Strength Index (14 RSI): 54.82 Buy
Chaikin Money Flow: 47423 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.35 - 14.87) Buy
Bollinger Bands (100): (14.69 - 15.55) Sell

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

SCD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.67 Buy
20-day SMA: 14.71 Buy
50-day SMA: 14.79 Buy
200-day SMA: 15.32 Sell
8-day EMA: 9.32 Buy
20-day EMA: 4.84 Buy
50-day EMA: 2.17 Buy
200-day EMA: 0.58 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

LMP Capital and Income Fund Earnings Growth & SCD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

LMP Capital and Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):